Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Algonist Biotechnologies logo — Targeting Chronic Pain

Algonist Biotechnologies

Targeting Chronic Pain

Founded 2020 Austria Austria 2 employees Series Unknown Biotechnology, Pharmaceutical

General Information

Company Name Algonist Biotechnologies
Founded Year 2020
Location Austria Austria +1
Employees 2
Industries Biotechnology, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Algonist Biotechnologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Algonist Biotechnologies

Algonist Biotechnologies is a pre-clinical stage biotechnology company, founded in 2020 and based in Austria, with a mission to address chronic pain. Their slogan, "Targeting Chronic Pain," encapsulates their focus on developing novel small molecule therapeutics for this pressing issue. The company aims to create drugs with similar potency to opioids but without the risk of addiction. Their most recent milestone was the Venture Round investment at 01 January 2023, and the investor was Kinled Holding Ltd. With a special emphasis on biotechnology and pharmaceuticals, Algonist Biotechnologies is positioned at the exciting intersection of cutting-edge science and critical unmet medical needs.

Taxonomy: chronic pain, small molecule therapeutics, opioids, addiction, pre-clinical stage, drug development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
01 Jan 2023

FAQ About Algonist Biotechnologies

Targeting Chronic Pain
Algonist Biotechnologies was founded in 2020.
Algonist Biotechnologies is headquartered in Austria.
Algonist Biotechnologies operates in the following industries: Biotechnology, Pharmaceutical.
Algonist Biotechnologies has approximately 2 employees.
Algonist Biotechnologies has completed 1 funding round. The latest funding stage is Series Unknown.

We're actively collecting intelligence on Algonist Biotechnologies.

Track Algonist Biotechnologies to get notified

Don't just browse. Track.

Signal Tracker monitors Algonist Biotechnologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy